Patent ID: 7163813

Claim:
A biological composition comprising activated yeast cells, wherein said activated yeast cells are cells of Saccharomyces cerevisiae Hansen strain AS2.1396 and are characterized by their ability to retard the growth of colorectal cancer cells in mammals as compared to yeast cells of said strain not having been so activated, wherein said activated yeast cells are prepared by using yeast cells of Saccharomyces cerevisiae Hansen strain AS2.1396 in a method comprising at least two steps selected from the group consisting of: (a) culturing said yeast cells in a first electromagnetic field having a frequency in the range of 7,941 to 7,950 MHz and a field strength in the range of 230 to 250 mV/cm; (b) culturing said yeast cells in a second electromagnetic field having a frequency in the range of 9,131 to 9,140 MHz and a field strength in the range of 220 to 240 mV/cm; (C) culturing said yeast cells in a third electromagnetic field having a frequency in the range of 9,991 to 10,000 MHz and a field strength in the range of 250 to 270 mV/cm; (d) culturing said yeast cells in a fourth electromagnetic field having a frequency in the range of 11,141 to 11,150 MHz and a field strength in the range of 230 to 250 mV/cm; and (e) culturing said yeast cells in a fifth electromagnetic field having a frequency in the range of 12,771 to 12,780 MHz and a field strength in the range of 260 to 280 mV/cm.